Immunovia's CLARITI study results selected for prestigious presentation at the world's largest gastroenterology conference ...Middle East

PR Newswire - News

LUND, Sweden, March 3, 2025 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the results of its CLARITI study have been selected for a distinguished plenary presentation at the upcoming Digestive Disease Week® (DDW) 2025...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Immunovia's CLARITI study results selected for prestigious presentation at the world's largest gastroenterology conference )

    Also on site :

    Most viewed in News